Mark Yandle

Mark Yandle has over two decades of experience in the pharmaceutical industry, primarily at Pfizer, where roles included Principal Scientist, Drug Substance 2 Technical Services Lead, and Senior Manager of Drug Substance Technical Services from July 2002 to March 2022. Currently, Mark serves as Co Dev Team Lead at Pfizer since March 2022. Prior to tenure at Pfizer, Mark worked as a Process Technologist at Lonza from 1999 to 2002. Mark Yandle holds a Master's in Business Studies with a focus on Strategy and Innovation / Organisational Behaviour from the Irish Management Institute (2018-2020), a Master's Degree in Molecular Biology and Biotechnology from UCL (1997-1998), and a Bachelor's Degree in Cell and Molecular Biology from Kingston University (1992-1995).